Mostrando 10 resultados de: 13
Filtros aplicados
Publisher
New England Journal of Medicine(3)
The Lancet(3)
American Journal of Hypertension(1)
Canadian Journal of Cardiology(1)
European Heart Journal(1)
Association of urinary sodium excretion with blood pressure and cardiovascular clinical events in 17,033 Latin americans
ArticleAbstract: BACKGROUND Information on actual sodium intake and its relationships with blood pressure (BP) and clPalabras claves:Blood pressure, Cardiovascular disease, Hypertension, Mortality , Sodium intakeAutores:Avezum A.J., Camacho-López P.A., DIaz R., Lamelas P.M., Lanas F., Mente A., Oliveira G.B.F., Orlandini A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Seron P., Teo K.K., Yusuf S.Fuentes:googlescopusAssociations of Fish Consumption with Risk of Cardiovascular Disease and Mortality among Individuals with or without Vascular Disease from 58 Countries
ArticleAbstract: Importance: Cohort studies report inconsistent associations between fish consumption, a major sourcePalabras claves:Autores:Alhabib K.F., Avezum A.J., Chifamba J., Dagenais G.R., Dans A.M., Dehghan M., DIaz R., Gerstein H.C., Gulec S., Gupta R., Hu W., Iqbal R., Kaur M., Khatib R., Lanas F.T., Lear S.A., Mente A., Mohammadifard N., Mohan D., Mohan V., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rosengren A., Swaminathan S., Szuba A., Teo K.K., Vijayakumar K., Wei L., Wentzel-Viljoen E., Wielgosz A., Yeates K.E., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusAssociations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies
ArticleAbstract: Background Several studies reported a U-shaped association between urinary sodium excretion and cardPalabras claves:Autores:Anand S.S., Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., DIaz R., Iqbal R., Lanas F., Lear S.A., Li W., Lu Y., Mann J.F.E., McQueen M.J., Mente A., Mony P.K., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rensheng L., Rosengren A., Schutte A.E., Szuba A., Teo K.K., Yi S., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusDietary sodium and cardiovascular disease risk
OtherAbstract:Palabras claves:Autores:Mann J.F.E., Mente A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Saulnier P.J., Schutte A.E., Staessen J.A., Thomas M., Yusuf S.Fuentes:googlescopusLong-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
ArticleAbstract: Aims: To describe outcomes of patients with chronic coronary artery disease (CAD) and/or peripheralPalabras claves:aspirin, Coronary artery disease, Peripheral artery disease, rivaroxabanAutores:Aboyans V., Alings M., Anand S.S., Avezum A.J., Bangdiwala S.I., Bhatt D.L., Bosch J.J., Branch K.R.H., Camillo Felix, Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.L., DIaz R., Eikelboom J.W., Ertl G., Fox K.A.A., Guzik T.J., Hori M., Ibrahim K.S., Kakkar A.K., Keltai K., Keltai M., Kim J.H., Lamy A., Lanas F., Leong D.P., Lewis B.S., Liang Y., Lonn E.M., Lopez-Jaramillo P., Maggioni A.P., Metsarinne K.P., Muehlhofer E., Neumann C., O’Donnell M., Parkhomenko A.N., Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Steg P.G., Stoerk S., Tasto C., Tonkin A.M., Torp-Pedersen C., Tyrwitt J., Vanassche T., Varigos J.D., Verhamme P.B., Vinereanu D., Widimsky P., Yusuf S., Zhu J.Fuentes:scopusJoint association of urinary sodium and potassium excretion with cardiovascular events and mortality: Prospective cohort study
ArticleAbstract: Objective: To evaluate the joint association of sodium and potassium urinary excretion (as surrogatePalabras claves:Autores:Alhabib K.F., Avezum A.J., Chifamba J., Dagenais G.R., Dans A.M., DIaz R., Ferguson J., Iqbal R., Khatib R., Kruger L., Lanas F.T., Lear S.A., Liu X., McQueen M.J., Mente A., Mohammadifard N., Noorhassim I., O'Leary N., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rosengren A., Smyth A., Swaminathan S., Szuba A., Teo K.K., Wielgosz A., Yeates K.E., Yin L., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusUrinary sodium and potassium excretion, mortality, and cardiovascular events
ArticleAbstract: BACKGROUND: The optimal range of sodium intake for cardiovascular health is controversial. METHODS:Palabras claves:Autores:Avezum A.J., Chifamba J., Dagenais G.R., Devanath A., DIaz R., Gulec S., Ilow R., Iqbal R., Kabali C., Kruger L., Lanas F., Lear S.A., Lee S.F., Liu L., McQueen M.J., Mente A., Mohammadifard N., Mony P.K., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rosengren A., Teo K.K., Wang X., Yan H., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusSalt and cardiovascular disease: Insufficient evidence to recommend low sodium intake
ArticleAbstract: Several blood pressure guidelines recommend low sodium intake (<2.3 g/day, 100 mmol, 5.8 g/day of saPalabras claves:Cardiovascular, diet, prevention, SaltAutores:Alderman M.H., Brady A.J.B., DIaz R., Gupta R., Luft F.C., Lüscher T.F., Mancia G., Mann J.F.E., McCarron D., Mckee M., Mente A., Messerli F.H., Moore L.L., Narula J., Oparil S., O’Donnell M., Packer M., PATRICIO LOPEZ -JARAMILLO, Prabhakaran D., Schutte A.E., Sliwa K., Staessen J.A., Yancy C., Yusuf S.Fuentes:googlescopusRationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
ArticleAbstract: Background Long-term aspirin prevents vascular events but is only modestly effective. Rivaroxaban alPalabras claves:Autores:Aboyans V., Alings M., Anand S.S., Avezum A.J., Bhatt D.L., Bosch J.J., Branch K.R.H., Bruns N.C., Chen E., Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.M., DIaz R., Eikelboom J.W., Ertl G., Felix Camilo, Fox K.A.A., Guzik T.J., Ha J.W., Hart R.G., Hori M., Kakkar A.K., Keltai K., Keltai M., Kim J.H., Lamy A., Lanas F., Lanius V., Leong D.P., Lewis B.S., Liang Y., Liu L., Lonn E.M., Maggioni A.P., Metsarinne K.P., Misselwitz F., Moayyedi P., O’Donnell M., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Steg P.G., Störk S., Tonkin A.M., Torp-Pedersen C., Varigos J.D., Verhamme P.B., Vinereanu D., Widimsky P., Yuan F., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusRationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial
ArticleAbstract: Background: Covert vascular disease of the brain manifests as infarcts, white matter hyperintensitiePalabras claves:Anticoagulant, Clinical trial, COGNITION, magnetic resonance imaging, prevention, silent infarctAutores:Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Casanova A., Connolly S.J., Cook-Bruns N., Dagenais G.R., DIaz R., Eikelboom J.W., Ertl G., Fox K.A.A., Ha J.W., Hart R.G., Keltai K., Keltai M., Kim J.H., Liang Y., Liu L., Lonn E.M., Maggioni A.P., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Smith E.E., Störk S., Tonkin A.M., Varigos J.D., Vinereanu D., Wong G., Yuan F., Yusuf S., Zhu J.Fuentes:googlescopus